Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 65,793	$ 96,876
Restricted cash	0	6,987
Short-term investments	9,260	119,614
Equity securities	0	384
Receivables
Trade, net	20,650	21,179
Related parties, net	600	4,129
Other	4,978	1,257
Inventory	16,097	20,575
Prepaid expenses and other	6,444	5,327
Current assets held for sale	110,821	9,155
Total current assets	234,643	285,483
Equity securities, noncurrent	0	640
Property, plant and equipment, net	60,969	86,896
Intangible assets, net	68,346	88,962
Goodwill	63,754	93,627
Investments in affiliates	1,461	2,139
Right-of-use assets	25,228
Other assets	1,362	2,069
Noncurrent assets held for sale	0	156,361
Total assets	455,763	716,177
Current liabilities
Accounts payable	5,917	11,973
Accrued compensation and benefits	14,091	9,955
Other accrued liabilities	12,049	19,005
Deferred revenue, including $877 and $6,502 from related parties as of December 31, 2019 and 2018, respectively	5,697	11,088
Lines of credit	1,922	466
Current portion of long-term debt, including $31,211 and $0 to related parties as of December 31, 2019 and 2018, respectively	31,670	479
Current portion of lease liabilities	4,182
Related party payables	51	256
Current liabilities held for sale	47,333	8,340
Total current liabilities	122,912	61,562
Long-term debt, net of current portion, including $25,000 and $55,290 to related parties as of December 31, 2019 and 2018, respectively	186,321	211,216
Deferred revenue, net of current portion, including $30,182 and $44,772 from related parties as of December 31, 2019 and 2018, respectively	48,136	46,728
Lease liabilities, net of current portion	23,849
Deferred tax liabilities	2,834	3,856
Other long-term liabilities	0	3,135
Long-term liabilities held for sale	0	10,958
Total liabilities	384,052	337,455
Commitments and contingencies (Note 17)
Total equity
Common stock, no par value, 400,000,000 shares and 200,000,000 shares authorized as of December 31, 2019 and 2018, respectively; and 163,274,880 shares and 160,020,466 shares issued and outstanding as of December 31, 2019 and 2018, respectively	0	0
Additional paid-in capital	1,752,048	1,722,012
Accumulated deficit	(1,652,869)	(1,330,545)
Accumulated other comprehensive loss	(27,468)	(28,612)
Total Precigen shareholders' equity	71,711	362,855
Noncontrolling interests	0	15,867
Total equity	71,711	378,722
Total liabilities and total equity	$ 455,763	$ 716,177